John F. Sheridan - 18 Feb 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
PRESIDENT & CEO, Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for John F. Sheridan
Issuer symbol
TNDM
Transactions as of
18 Feb 2025
Net transactions value
-$106,502
Form type
4
Filing time
20 Feb 2025, 17:07:16 UTC
Previous filing
19 Nov 2024
Next filing
27 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +793 +1.5% $0.000000 55,130 18 Feb 2025 Direct
transaction TNDM Common Stock Tax liability $9,505 -284 -0.52% $33.47 54,846 18 Feb 2025 Direct F1
transaction TNDM Common Stock Options Exercise $0 +2,237 +4.1% $0.000000 57,083 18 Feb 2025 Direct
transaction TNDM Common Stock Tax liability $26,809 -801 -1.4% $33.47 56,282 18 Feb 2025 Direct F1
transaction TNDM Common Stock Options Exercise $0 +5,472 +9.7% $0.000000 61,754 18 Feb 2025 Direct
transaction TNDM Common Stock Tax liability $70,187 -2,097 -3.4% $33.47 59,657 18 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -793 -50% $0.000000 792 18 Feb 2025 Common Stock 793 Direct F2, F3, F4
transaction TNDM Restricted Stock Unit Options Exercise $0 -2,237 -50% $0.000000 2,236 18 Feb 2025 Common Stock 2,237 Direct F3, F5, F6
transaction TNDM Restricted Stock Unit Options Exercise $0 -5,472 -17% $0.000000 27,358 18 Feb 2025 Common Stock 5,472 Direct F7, F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
F5 Awarded on May 25, 2022 pursuant to the 2013 Plan.
F6 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
F7 Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F8 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F9 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.